Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Intellia Thera CS (NTLA)

Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,336,259
  • Shares Outstanding, K 101,849
  • Annual Sales, $ 36,280 K
  • Annual Income, $ -481,190 K
  • EBIT $ -538 M
  • EBITDA $ -529 M
  • 60-Month Beta 1.81
  • Price/Sales 39.67
  • Price/Cash Flow N/A
  • Price/Book 1.49

Options Overview Details

View History
  • Implied Volatility 78.43% ( +2.25%)
  • Historical Volatility 94.04%
  • IV Percentile 85%
  • IV Rank 46.09%
  • IV High 106.41% on 11/15/24
  • IV Low 54.50% on 08/21/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 1,826
  • Volume Avg (30-Day) 3,578
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 42,824
  • Open Int (30-Day) 39,539

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.36
  • Number of Estimates 13
  • High Estimate -0.88
  • Low Estimate -1.61
  • Prior Year -1.46
  • Growth Rate Est. (year over year) +6.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.82 +10.10%
on 11/20/24
21.17 -33.33%
on 10/23/24
-6.56 (-31.71%)
since 10/21/24
3-Month
12.82 +10.10%
on 11/20/24
24.16 -41.58%
on 08/23/24
-9.50 (-40.22%)
since 08/21/24
52-Week
12.82 +10.10%
on 11/20/24
34.87 -59.52%
on 02/29/24
-14.34 (-50.40%)
since 11/21/23

Most Recent Stories

More News
Intellia Therapeutics Reports Promising Phase 1 Trial Results for Nexiguran Ziclumeran in ATTR Amyloidosis

Intellia Therapeutics announces positive Phase 1 trial results for nex-z in ATTR amyloidosis, indicating significant TTR reduction and disease stabilization.Quiver AI SummaryIntellia Therapeutics announced...

NTLA : 14.02 (+6.86%)
Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis

NTLA : 14.02 (+6.86%)
3 Fast-Growing Stocks Analysts See Doubling in Price

Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.

IMCR : 31.97 (-1.39%)
GHRS : 9.69 (-11.55%)
NTLA : 14.02 (+6.86%)
Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress

NTLA : 14.02 (+6.86%)
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?

There's nothing bearish at all about what it reported recently.

NTLA : 14.02 (+6.86%)
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NTLA : 14.02 (+6.86%)
This Beaten-Down Stock Could Soar by 354%, According to Wall Street

Maybe the Street is a bit too optimistic on this one.

NTLA : 14.02 (+6.86%)
Intellia Therapeutics Announces Two Upcoming Investor Events in November 2024

NTLA : 14.02 (+6.86%)
12 High-Growth Stocks That Could Deliver Parabolic Returns

These 12 innovative companies could deliver exponential returns over the next quarter century.

NVDA : 147.94 (+1.41%)
NVTS : 1.9900 (+8.74%)
VRTX : 450.26 (-0.21%)
RKLB : 22.31 (+10.56%)
LUNR : 13.86 (+14.83%)
SERV : 8.52 (-2.52%)
ACHR : 5.83 (+15.22%)
TSLA : 341.08 (-0.28%)
CRSP : 45.96 (-2.75%)
SOUN : 7.03 (+9.16%)
APLD : 9.46 (+7.99%)
TM : 173.51 (+0.35%)
Why Intellia Therapeutics Stock Plummeted by 20% Today

Seemingly encouraging results from the lab were met with some notable skepticism.

NTLA : 14.02 (+6.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Intellia Therapeutics is a leading clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. The company is pursuing two primary approaches to fully realize the transformative potential of CRISPR/Cas9 in vivo programs that use intravenously administered CRISPR as the...

See More

Key Turning Points

3rd Resistance Point 15.44
2nd Resistance Point 14.85
1st Resistance Point 13.99
Last Price 14.02
1st Support Level 12.54
2nd Support Level 11.95
3rd Support Level 11.09

See More

52-Week High 34.87
Fibonacci 61.8% 26.45
Fibonacci 50% 23.84
Fibonacci 38.2% 21.24
Last Price 14.02
52-Week Low 12.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar